SecSonar.com

Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Biodexa Pharmaceuticals Plc (BDRX) is a Biotechnology company based in GB with a market capitalization of $573.7K. Free cash flow was negative at -$7.2M. This page tracks BDRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 13 employees · IPO Dec 7, 2015

Valuation

Valuation & price

$3.33 · as of May 26, 2026 · -93.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$45.95$24.28$2.61Jul 25Dec 25Jul 26Jul 7, 25$43.30Jul 9, 25$43.85Jul 11, 25$43.70Jul 15, 25$44.00Jul 17, 25$42.60Jul 21, 25$42.50Jul 23, 25$44.10Jul 25, 25$44.00Jul 29, 25$43.00Jul 31, 25$39.25Aug 4, 25$34.90Aug 6, 25$33.80Aug 11, 25$34.50Aug 13, 25$34.55Aug 15, 25$35.20Aug 19, 25$34.35Aug 21, 25$33.75Aug 25, 25$31.05Aug 27, 25$28.55Aug 29, 25$27.70Sep 3, 25$28.45Sep 5, 25$28.25Sep 9, 25$28.05Sep 11, 25$29.65Sep 16, 25$31.30Sep 18, 25$32.60Sep 22, 25$33.10Sep 24, 25$32.05Sep 26, 25$31.75Sep 30, 25$33.25Oct 2, 25$33.35Oct 6, 25$33.15Oct 8, 25$38.55Oct 10, 25$45.95Oct 14, 25$42.00Oct 16, 25$41.70Oct 21, 25$37.75Oct 23, 25$34.00Oct 27, 25$37.25Oct 29, 25$29.70Oct 31, 25$31.65Nov 4, 25$27.00Nov 6, 25$26.45Nov 10, 25$26.70Nov 12, 25$26.85Nov 14, 25$27.40Nov 18, 25$23.00Nov 20, 25$19.65Nov 25, 25$19.55Nov 28, 25$22.65Dec 2, 25$24.30Dec 4, 25$25.45Dec 8, 25$44.00Dec 10, 25$33.60Dec 12, 25$23.75Dec 16, 25$32.50Dec 18, 25$20.75Dec 22, 25$16.60Dec 24, 25$14.15Dec 29, 25$11.60Jan 2, 26$12.30Jan 6, 26$12.25Jan 8, 26$11.55Jan 12, 26$11.65Jan 14, 26$10.45Jan 16, 26$11.20Jan 21, 26$10.50Jan 23, 26$10.75Jan 27, 26$10.80Jan 29, 26$9.20Feb 2, 26$8.50Feb 4, 26$7.25Feb 9, 26$6.50Feb 11, 26$6.05Feb 13, 26$5.40Feb 18, 26$6.25Feb 20, 26$5.80Feb 24, 26$5.60Feb 26, 26$5.65Mar 2, 26$5.05Mar 4, 26$4.70Mar 6, 26$4.53Mar 10, 26$4.75Mar 12, 26$4.33Mar 17, 26$3.94Mar 19, 26$3.43Mar 23, 26$3.42Mar 25, 26$3.45Mar 27, 26$3.27Mar 31, 26$3.09Apr 2, 26$4.37Apr 7, 26$3.35Apr 9, 26$3.25Apr 13, 26$3.10Apr 15, 26$3.43Apr 17, 26$3.48Apr 22, 26$3.89Apr 24, 26$3.30Apr 28, 26$3.30Apr 30, 26$3.14May 4, 26$3.12May 6, 26$4.42May 8, 26$4.25May 12, 26$3.80May 14, 26$3.40May 18, 26$3.15May 20, 26$3.11May 22, 26$3.28May 28, 26$3.36Jun 1, 26$3.32Jun 3, 26$3.59Jun 5, 26$3.36Jun 9, 26$3.10Jun 11, 26$3.08Jun 15, 26$3.07Jun 17, 26$3.01Jun 22, 26$3.01Jun 24, 26$2.61Jun 26, 26$2.92Jul 2, 26$2.94
$2.5052-week range$54.50
Loading valuation history…

Fundamentals

Key fundamentals

$573.7K

Market cap

—

Revenue growth (YoY)

-967.5%

Gross margin

-$7.2M

Free cash flow (USD)

-$8.5M

Net debt

Net cash position

-11.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.3MFY 2017$989.0KFY 2018$1.9MFY 2019$674.0KFY 2020$343.0KFY 2021$578.0KFY 2022$699.0KFY 2023$381.0KFY 2024$0.00FY 2025$0.00
$1.3M$0

Free cash flow by year

2016 → 2025

FY 2016$-14.4MFY 2017$-13.7MFY 2018$-13.7MFY 2019$-6.8MFY 2020$-9.5MFY 2021$-6.3MFY 2022$-7.1MFY 2023$-7.1MFY 2024$-13.0MFY 2025$-5.4M
-$14.4M-$5.4M

Gross margin by year

2021 → 2023

FY 2021-705.2%FY 2022-631.2%FY 2023-967.5%
-705.2%-967.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 14, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingRegistered Direct OfferingJun 30, 2026Filing
  • 6-K filingAnnual General Meeting ResultsJun 30, 2026Filing
  • 6-K filingSecurities Purchase AgreementJun 30, 2026Filing
  • 6-K filingAnnual General Meeting RescheduledJun 17, 2026Filing
  • Annual reportAnnual Report FiledMay 14, 2026Filing

Questions

Frequently asked questions

What is Biodexa Pharmaceuticals Plc's market cap?

Biodexa Pharmaceuticals Plc (BDRX) has a market capitalization of $573.7K.

What is BDRX's P/E ratio?

A meaningful P/E ratio is not available for BDRX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying BDRX stock?

SEC Form 4 filings show no open-market insider buys at Biodexa Pharmaceuticals Plc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

SCNI

Scinai Immunotherapeutics Ltd.

$604.8K

SPRC

SciSparc Ltd.

$523.4K

ASBP

Aspire Biopharma Holdings, Inc.

$627.6K

ONCO

Onconetix, Inc.

$400.8K

PPBT

Purple Biotech Ltd.

$396K

VRAX

Virax Biolabs Group Limited

$769K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.